Related Experiment Video
Updated: Dec 11, 2025
05:36
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
Published on: February 23, 2024
776
Endogenous Labile Iron Pool-Mediated Free Radical Generation for Cancer Chemodynamic Therapy
Lisen Lin1,2,3, Sheng Wang4, Hongzhang Deng3
1Department of Ultrasound Medicine, Laboratory of Ultrasound Molecular Imaging, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China.
Journal of the American Chemical Society
|August 22, 2020
Summary
This study introduces a novel cancer treatment using the body's own iron (labile iron pool) to activate hydroperoxides for targeted cell death. This approach avoids toxic heavy metals, enhancing chemodynamic therapy (CDT) safety and efficacy.
Area of Science:
- Biomedical Engineering
- Nanomedicine
- Cancer Therapy
Background:
- Current chemodynamic therapy (CDT) uses external heavy metals, posing health risks.
- Hydroxyl radical production is key to CDT efficacy.
- Exogenous metal administration can lead to adverse health effects.
Purpose of the Study:
- To develop a safer CDT strategy utilizing the body's endogenous iron.
- To identify optimal chemodynamic agents activated by intracellular labile iron pool (LIP).
- To create responsive nanomedicines for enhanced cancer treatment.
Main Methods:
- Investigated hydroperoxides (R'OOH) as LIP-mediated agents.
- Simulated metabolic pathways of R'OOH within cells.
- Fabricated pH/labile iron(II) cascade-responsive nanomedicines.
Main Results:
- R'OOH demonstrated potent free radical generation with LIP.
- R'OOH showed moderate resistance to cellular detoxification (glutathione/glutathione peroxidase).
- Developed nanomedicines enhanced CDT specificity and efficacy.
Conclusions:
- Endogenous LIP can be used for safe and effective cancer CDT.
- R'OOH represents a promising LIP-activated chemodynamic agent.
- This strategy offers a new paradigm for chemodynamic agent development.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
17.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
17.8K
02:57Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
02:50Combination Therapies and Personalized Medicine
5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
01:15Drugs that Stabilize Microtubules
2.5K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K